ETX-19477 is a potent, selective inhibitor of poly (ADP-ribose) glycohydrolase (PARG), an enzyme that plays a role in the DNA ...

Zilganersen is an investigational antisense oligonucleotide designed to stop excess GFAP production. The Food and Drug Administration (FDA) has granted Fast Track designation to zilganersen for the ...

The therapy is expected to block abnormal blood vessel growth, limit vascular leakage, and reduce retina damage. The Food and Drug Administration (FDA) has granted Fast Track designation to SAR402663 ...

The Food and Drug Administration will fast-track the development of AC699 for patients with ER-positive, HER2-negative ESR1-mutant advanced or metastatic breast cancer. The Food and Drug ...

Liafensine is an investigational, biomarker-based precision medicine for TRD. The Food and Drug Administration (FDA) has granted Fast Track designation to liafensine (DB104) for patients with ...

In preclinical prostate cancer models, HLD-0915 treatment resulted in tumor shrinkage and declines in prostate-specific antigen. The Food and Drug Administration (FDA) has granted Fast Track ...

The Trump administration has identified hundreds of “emergency” energy projects whose approvals could be fast-tracked. The U.S. Army Corps of Engineers has updated its website to put hundreds of new ...

An error has occurred. Please try again. With a The Portland Press Herald subscription, you can gift 5 articles each month. It looks like you do not have any active ...

WHAT’S HAPPENING TODAY: Good afternoon and happy Thursday, readers! In today’s Daily on Energy, we explore a newly approved graphite mining project in Alaska that will be covered by the federal ...